Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB26FSU80
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUCALA 100 mg/mL auto-injector units. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, carries no set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group will perform the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy that establishes multiple regional prime vendor contractors to support Department of Defense medical supply requirements globally. The PPV-G GEN V contract, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements within the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FSU80?
SPE2DB26FSU80 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FSU80 worth?
The government has obligated $3,786 on SPE2DB26FSU80.
Is contract SPE2DB26FSU80 an order under another contract?
Yes. SPE2DB26FSU80 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB26FSU80 competed?
The extent of competition for SPE2DB26FSU80 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award